aluris logo
aluris logo

CASE STUDIES >

Discover how we’ve partnered with life sciences innovators to take their products from development through to commercial-scale manufacturing.

TALK TO AN EXPERT >

From process development to full-scale production, see how we’ve helped companies navigate complexity and deliver at scale.

customer first solutions

Life Sciences | Combination and Drug Product Manufacturing | Lyophilization

meeting-male
  • 23 July 2026
  • / V-Franks
Contract Manufacturing in Biotech — Turning Your Supply Chain into a Competitive Differentiator
This whitepaper argues that contract manufacturing is not just a cost-saving tactic but can be a strategic differentiator for a biotech’s supply chain when done well.
Read More
4-meeting-woman
  • 23 July 2026
  • / V-Franks
How to Eliminate Hidden Cold Chain Costs — Lyophilizing in vitro Diagnostic Assays
This whitepaper presents a Total Landed Cost (TLC) analysis comparing cold-chain shipping of liquid diagnostic reagent kits against ambient shipping of the same kit in lyophilized form, arguing that lyophilization saves money once all shipping and packaging costs are counted, not just the sticker price of the product.
Read More
7-groupin-breakoutmeeting
  • 23 July 2026
  • / V-Franks
Increase Your Profit Margin with Lyophilization — Benefits for Reagent Kits & in vitro Diagnostics
This whitepaper argues that lyophilization is a margin-improvement lever for reagent kit and in vitro diagnostics manufacturers, not just a technical/logistics choice.
Read More
1-purple-blister-pack
  • 23 July 2026
  • / V-Franks
Optimize Your Strategy to Reduce IVD Reagent Carbon Footprint
This whitepaper frames lyophilization as an environmental sustainability (ESG) strategy for IVD reagent manufacturers, in addition to its cost and logistics benefits, positioning ambient-stable shipping as a way to cut a diagnostics company’s carbon footprint.
Read More
6-TWO-PEOPLE
  • 23 July 2026
  • / V-Franks
Elevate and Transform Molecular in vitro Diagnostics Industry with the Foundry Model
This whitepaper draws an analogy between the semiconductor industry’s ‘foundry model’ (exemplified by TSMC) and an opportunity for the molecular in vitro diagnostics manufacturing industry to adopt a similar shared-infrastructure, variable-cost manufacturing approach.
Read More
Services Template 1080x1080 image9
  • 23 July 2026
  • / V-Franks
Strategic Outsourcing in Biotech — Key Decisions and Processes
This case study walks through the decision process of an (unnamed) NGS diagnostics company deciding whether to build internal cGMP manufacturing capacity or outsource, and how it selected and worked with a contract manufacturer.
Read More
aluris logo
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.